Iris Pharma   Report issue

For profit Phase 2 Phase 4
Founded: La Gaude France (1989)

Organization Overview

First Clinical Trial
2017
NCT03009799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

IRIS Research and Development, LLC